| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Review |
1 School of Biology, University of St Andrews, The North Haugh, St Andrews KY16 9ST, UK
2 Division of Basic Medical Sciences, St George's, University of London, London SW17 0RE, UK
Correspondence
Richard E. Randall
rer{at}st-andrews.ac.uk
Stephen Goodbourn
s.goodbourn{at}sgul.ac.uk
The interferon (IFN) system is an extremely powerful antiviral response that is capable of controlling most, if not all, virus infections in the absence of adaptive immunity. However, viruses can still replicate and cause disease in vivo, because they have some strategy for at least partially circumventing the IFN response. We reviewed this topic in 2000 [Goodbourn, S., Didcock, L. & Randall, R. E. (2000). J Gen Virol 81, 2341–2364] but, since then, a great deal has been discovered about the molecular mechanisms of the IFN response and how different viruses circumvent it. This information is of fundamental interest, but may also have practical application in the design and manufacture of attenuated virus vaccines and the development of novel antiviral drugs. In the first part of this review, we describe how viruses activate the IFN system, how IFNs induce transcription of their target genes and the mechanism of action of IFN-induced proteins with antiviral action. In the second part, we describe how viruses circumvent the IFN response. Here, we reflect upon possible consequences for both the virus and host of the different strategies that viruses have evolved and discuss whether certain viruses have exploited the IFN response to modulate their life cycle (e.g. to establish and maintain persistent/latent infections), whether perturbation of the IFN response by persistent infections can lead to chronic disease, and the importance of the IFN system as a species barrier to virus infections. Lastly, we briefly describe applied aspects that arise from an increase in our knowledge in this area, including vaccine design and manufacture, the development of novel antiviral drugs and the use of IFN-sensitive oncolytic viruses in the treatment of cancer.
Published online ahead of print on 8 November 2007 as DOI 10.1099/vir.0.83391-0.
This article has been cited by other articles:
|
|
 |
|
  C. Myskiw, J. Arsenio, R. van Bruggen, Y. Deschambault, and J. Cao Vaccinia Virus E3 Suppresses Expression of Diverse Cytokines through Inhibition of the PKR, NF-{kappa}B, and IRF3 Pathways J. Virol., July 1, 2009; 83(13): 6757 - 6768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Wu, Y. Zhu, D. M. Bisaro, and D. S. Parris Herpes Simplex Virus Type 1 Suppresses RNA-Induced Gene Silencing in Mammalian Cells J. Virol., July 1, 2009; 83(13): 6652 - 6663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Christian, T. W. Collier, D. Zu, M. Licursi, C. M. Hough, and K. Hirasawa Activated Ras/MEK Inhibits the Antiviral Response of Alpha Interferon by Reducing STAT2 Levels J. Virol., July 1, 2009; 83(13): 6717 - 6726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-L. Siu, K.-H. Kok, M.-H. J. Ng, V. K. M. Poon, K.-Y. Yuen, B.-J. Zheng, and D.-Y. Jin Severe Acute Respiratory Syndrome Coronavirus M Protein Inhibits Type I Interferon Production by Impeding the Formation of TRAF3{middle dot}TANK{middle dot}TBK1/IKK{epsilon} Complex J. Biol. Chem., June 12, 2009; 284(24): 16202 - 16209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Wang, J. W. Barrett, Y. Ma, G. A. Dekaban, and G. McFadden Induction of Alpha/Beta Interferon by Myxoma Virus Is Selectively Abrogated When Primary Mouse Embryo Fibroblasts Become Immortalized J. Virol., June 1, 2009; 83(11): 5928 - 5932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zhang, J. O. Langland, B. L. Jacobs, and C. E. Samuel Protein Kinase PKR-Dependent Activation of Mitogen-Activated Protein Kinases Occurs through Mitochondrial Adapter IPS-1 and Is Antagonized by Vaccinia Virus E3L J. Virol., June 1, 2009; 83(11): 5718 - 5725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A.L. Short Viral evasion of interferon stimulated genes Bioscience Horizons, June 1, 2009; 2(2): 212 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Holloway, T. T. Truong, and B. S. Coulson Rotavirus Antagonizes Cellular Antiviral Responses by Inhibiting the Nuclear Accumulation of STAT1, STAT2, and NF-{kappa}B J. Virol., May 15, 2009; 83(10): 4942 - 4951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Everett and A. Orr Herpes Simplex Virus Type 1 Regulatory Protein ICP0 Aids Infection in Cells with a Preinduced Interferon Response but Does Not Impede Interferon-Induced Gene Induction J. Virol., May 15, 2009; 83(10): 4978 - 4983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Morrison and V. R. Racaniello Proteinase 2Apro Is Essential for Enterovirus Replication in Type I Interferon-Treated Cells J. Virol., May 1, 2009; 83(9): 4412 - 4422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Habjan, A. Pichlmair, R. M. Elliott, A. K. Overby, T. Glatter, M. Gstaiger, G. Superti-Furga, H. Unger, and F. Weber NSs Protein of Rift Valley Fever Virus Induces the Specific Degradation of the Double-Stranded RNA-Dependent Protein Kinase J. Virol., May 1, 2009; 83(9): 4365 - 4375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Hou, X. Wang, L. Ye, L. Zhou, Z.-Q. Yang, E. Riedel, and W.-Z. Ho Lambda Interferon Inhibits Human Immunodeficiency Virus Type 1 Infection of Macrophages J. Virol., April 15, 2009; 83(8): 3834 - 3842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Trilling, V. T. K. Le, A. Zimmermann, H. Ludwig, K. Pfeffer, G. Sutter, G. L. Smith, and H. Hengel Gamma Interferon-Induced Interferon Regulatory Factor 1-Dependent Antiviral Response Inhibits Vaccinia Virus Replication in Mouse but Not Human Fibroblasts J. Virol., April 15, 2009; 83(8): 3684 - 3695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Pasieka, C. Cilloniz, B. Lu, T. H. Teal, S. C. Proll, M. G. Katze, and D. A. Leib Host Responses to Wild-Type and Attenuated Herpes Simplex Virus Infection in the Absence of Stat1 J. Virol., March 1, 2009; 83(5): 2075 - 2087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zurney, T. Kobayashi, G. H. Holm, T. S. Dermody, and B. Sherry Reovirus {micro}2 Protein Inhibits Interferon Signaling through a Novel Mechanism Involving Nuclear Accumulation of Interferon Regulatory Factor 9 J. Virol., March 1, 2009; 83(5): 2178 - 2187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Handke, R. Oelschlegel, R. Franke, D. H. Kruger, and A. Rang Hantaan Virus Triggers TLR3-Dependent Innate Immune Responses J. Immunol., March 1, 2009; 182(5): 2849 - 2858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. J. Buchholz, J. M. Ward, E. W. Lamirande, B. Heinze, C. D. Krempl, and P. L. Collins Deletion of Nonstructural Proteins NS1 and NS2 from Pneumonia Virus of Mice Attenuates Viral Replication and Reduces Pulmonary Cytokine Expression and Disease J. Virol., February 15, 2009; 83(4): 1969 - 1980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Childs, J. Andrejeva, R. E. Randall, and S. Goodbourn Mechanism of mda-5 Inhibition by Paramyxovirus V Proteins J. Virol., February 1, 2009; 83(3): 1465 - 1473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ruggli, A. Summerfield, A. R. Fiebach, L. Guzylack-Piriou, O. Bauhofer, C. G. Lamm, S. Waltersperger, K. Matsuno, L. Liu, M. Gerber, et al. Classical Swine Fever Virus Can Remain Virulent after Specific Elimination of the Interferon Regulatory Factor 3-Degrading Function of Npro J. Virol., January 15, 2009; 83(2): 817 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Toth, P. Devaux, R. Cattaneo, and C. E. Samuel Protein Kinase PKR Mediates the Apoptosis Induction and Growth Restriction Phenotypes of C Protein-Deficient Measles Virus J. Virol., January 15, 2009; 83(2): 961 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Russell Adenoviruses: update on structure and function J. Gen. Virol., January 1, 2009; 90(1): 1 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zhang and C. E. Samuel Induction of Protein Kinase PKR-dependent Activation of Interferon Regulatory Factor 3 by Vaccinia Virus Occurs through Adapter IPS-1 Signaling J. Biol. Chem., December 12, 2008; 283(50): 34580 - 34587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Davis, S. M. Sagan, J. P. Pezacki, D. J. Evans, and P. Simmonds Bioinformatic and Physical Characterizations of Genome-Scale Ordered RNA Structure in Mammalian RNA Viruses J. Virol., December 1, 2008; 82(23): 11824 - 11836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Vogt, E. Preuss, D. Mayer, F. Weber, M. Schwemmle, and G. Kochs The Interferon Antagonist ML Protein of Thogoto Virus Targets General Transcription Factor IIB J. Virol., November 15, 2008; 82(22): 11446 - 11453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Luthra, D. Sun, M. Wolfgang, and B. He AKT1-Dependent Activation of NF-{kappa}B by the L Protein of Parainfluenza Virus 5 J. Virol., November 1, 2008; 82(21): 10887 - 10895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Takeuchi, T. Komatsu, Y. Kitagawa, K. Sada, and B. Gotoh Sendai Virus C Protein Plays a Role in Restricting PKR Activation by Limiting the Generation of Intracellular Double-Stranded RNA J. Virol., October 15, 2008; 82(20): 10102 - 10110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. G. Hale, R. E. Randall, J. Ortin, and D. Jackson The multifunctional NS1 protein of influenza A viruses J. Gen. Virol., October 1, 2008; 89(10): 2359 - 2376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Magkouras, P. Matzener, T. Rumenapf, E. Peterhans, and M. Schweizer RNase-dependent inhibition of extracellular, but not intracellular, dsRNA-induced interferon synthesis by Erns of pestiviruses J. Gen. Virol., October 1, 2008; 89(10): 2501 - 2506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nakatsu, M. Takeda, S. Ohno, Y. Shirogane, M. Iwasaki, and Y. Yanagi Measles Virus Circumvents the Host Interferon Response by Different Actions of the C and V Proteins J. Virol., September 1, 2008; 82(17): 8296 - 8306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Everett, D. F. Young, R. E. Randall, and A. Orr STAT-1- and IRF-3-Dependent Pathways Are Not Essential for Repression of ICP0-Null Mutant Herpes Simplex Virus Type 1 in Human Fibroblasts J. Virol., September 1, 2008; 82(17): 8871 - 8881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Devaux, G. Hodge, M. B. McChesney, and R. Cattaneo Attenuation of V- or C-Defective Measles Viruses: Infection Control by the Inflammatory and Interferon Responses of Rhesus Monkeys J. Virol., June 1, 2008; 82(11): 5359 - 5367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Feld, V. M. Shpacovitch, C. Ehrhardt, C. Kerkhoff, M. D. Hollenberg, N. Vergnolle, S. Ludwig, and M. Steinhoff Agonists of Proteinase-Activated Receptor-2 Enhance IFN-{gamma}-Inducible Effects on Human Monocytes: Role in Influenza A Infection J. Immunol., May 15, 2008; 180(10): 6903 - 6910. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
